Marek Krogulec
Marek Krogulec publishes mostly in Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging, on topics such as Rheumatoid Arthritis Research and Therapies, Biosimilars and Bioanalytical Methods and Monoclonal and Polyclonal Antibodies Research.
- World rank
- #1,763,215 of 7,710,434 ranked researchers
- Rank in Poland
- #10,525 of 100,960
- Works
- 23
- Citations
- 1.7k
- Citations per work
- 75.4
What does Marek Krogulec research?
Marek Krogulec's work is mostly in Medicine (55%), Immunology and Microbiology (22%), Biochemistry, Genetics and Molecular Biology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1355.4%
- Medicine1355.4%
- Life Sciences624.6%
- Everything else520.0%
- 1Rheumatology38% of their works
- 2Immunology22% of their works
- 3Radiology, Nuclear Medicine and Imaging9% of their works
- 4Hematology5% of their works
- 5Genetics3% of their works
- 6Cancer Research3% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Biosimilars and Bioanalytical Methods
- Monoclonal and Polyclonal Antibodies Research
- Spondyloarthritis Studies and Treatments
- Autoimmune and Inflammatory Disorders Research
- Systemic Lupus Erythematosus Research
- Psoriasis: Treatment and Pathogenesis
- Chronic Lymphocytic Leukemia Research
Which keywords describe Marek Krogulec's research?
The keywords of their largest research topics: Autoantibodies, Monoclonal Antibodies, Inflammation, Rheumatoid Arthritis, Biosimilars, Immunogenicity, Fc Receptors and Therapeutic Antibodies.
- TH17 Cells
- Genomic Aberrations
- Systemic Lupus Erythematosus
- Hemophagocytic Lymphohistiocytosis
- Spondyloarthritis
- Therapeutic Antibodies
- Immunogenicity
- Rheumatoid Arthritis
- Monoclonal Antibodies
- Autoantibodies
- Inflammation
- Biosimilars
- Fc Receptors
- Ankylosing Spondylitis
- Antiphospholipid Syndrome
- Juvenile Idiopathic Arthritis
- Chronic Lymphocytic Leukemia
- IL-17
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Autoantibodies202 topics
- Monoclonal Antibodies182 topics
- Inflammation171 topic
- Rheumatoid Arthritis171 topic
- Biosimilars121 topic
- Immunogenicity121 topic
- Fc Receptors61 topic
- Therapeutic Antibodies61 topic
- Ankylosing Spondylitis51 topic
- Spondyloarthritis51 topic
- Antiphospholipid Syndrome31 topic
- Hemophagocytic Lymphohistiocytosis31 topic
- Juvenile Idiopathic Arthritis31 topic
- Systemic Lupus Erythematosus31 topic
- Chronic Lymphocytic Leukemia21 topic
- Genomic Aberrations21 topic
- IL-1721 topic
- TH17 Cells21 topic
Where does Marek Krogulec work?
Marek Krogulec's main affiliation in the publication record is Centrum Medyczne iMed24, Poland.
How many publications and citations does Marek Krogulec have?
OpenAlex counts 23 works and 1,735 citations for Marek Krogulec, an h-index of 10, ranking #1,763,215 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Marek Krogulec. Posts are plain text and can be reported.